Polypharmacy was associated with a greater risk of mortality and hospitalizations at one and five years. Evidence Rating ...
CDASI-A score at 12 weeks was significantly lower in dazukibart 600 mg versus placebo, suggesting reduced morbidity. 2.
From 2002 to 2021, the incidence rate of alcohol-associated hepatitis in Ontario, Canada increased by 8% annually, with rates ...
Association between blood–urea–nitrogen-to-albumin ratio and in-hospital mortality in patients diagnosed with coronavirus ...
In three cohorts of healthcare professionals, diet was associated with long-term health after adjusting for individual- and ...
In this cohort of adults in the United Kingdom (UK), those with a thinner or plumper body size in childhood had an increased ...
The composite of patient-reported clinical response and endoscopic response was significantly greater in mirikizumab versus ...
AURN001 demonstrates improvement of visual acuity in patients with corneal endothelial dysfunction. The CLARA trial demonstrates favorable safety profiles across all treatment arms. The Latest The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback